·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ Áß¶û±¸¾à, ¼¼ÀÌÇÁ¾à±¹ Âü¿©¾à»ç ´ë»ó ±³À° ±â»çÀÔ·Â : 19.06.21 08:59:31 0 °¡ ÇÃÄ£Ãß°¡ ¼¿ï Áß¶û±¸¾à»çȸ(ȸÀå ±èÀ§ÇÐ)´Â 19ÀÏ ±¸¾à»çȸ°ü¿¡¼ ¼¼ÀÌÇÁ¾à±¹ »ç¾÷ Âü¿©¾à±¹À» ´ë»óÀ¸·Î ±³À°À» ÁøÇàÇß´Ù. ±³À°Àº ¹ÚÇý°æ ÀǾàǰÁ¤Ã¥¿¬±¸¼ÒÀåÀÇ °ÀÇ·Î ¼¼ÀÌÇÁ¾à±¹ÀÇ ÃëÁö¿Í »ç¾÷¸ñÀû, »ó´ã¹æ¹ý µî ´Ù¾çÇÑ ³»¿ëÀ¸·Î ÁøÇàµÆ´Ù. Áß¶û±¸ ¼¼ÀÌÇÁ¾à±¹ »ç¾÷ Âü¿© ¾à±¹Àº °Ç°Á¦ÀϿ´©¸®¾à±¹, ¼ö¾à±¹, »ç°¡Á¤¾à±¹, ´ö¼ö¾à±¹, Çϳª¾à±¹, »õºÀȾ౹, ´ÃǪ¸¥¿Â´©¸®¾à±¹, Âü¾à»çM¹Ù¸¥¾à±¹, ¿À·»Áö¾à±¹, µ¿³²¾à±¹À¸·Î ÃÑ 10°÷ÀÌ´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ °½Å±¹ ±âÀÚ(ksk@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Áß¶û±¸¾à, ¼¼ÀÌÇÁ¾à±¹ Âü¿©¾à»ç ´ë»ó ±³À° URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Áß¶û±¸¾à, ¼¼ÀÌÇÁ¾à±¹ Âü¿©¾à»ç ´ë»ó ±³À° ±â»çÀÔ·Â : 19.06.21 08:59:31 0 °¡ ÇÃÄ£Ãß°¡ ¼¿ï Áß¶û±¸¾à»çȸ(ȸÀå ±èÀ§ÇÐ)´Â 19ÀÏ ±¸¾à»çȸ°ü¿¡¼ ¼¼ÀÌÇÁ¾à±¹ »ç¾÷ Âü¿©¾à±¹À» ´ë»óÀ¸·Î ±³À°À» ÁøÇàÇß´Ù. ±³À°Àº ¹ÚÇý°æ ÀǾàǰÁ¤Ã¥¿¬±¸¼ÒÀåÀÇ °ÀÇ·Î ¼¼ÀÌÇÁ¾à±¹ÀÇ ÃëÁö¿Í »ç¾÷¸ñÀû, »ó´ã¹æ¹ý µî ´Ù¾çÇÑ ³»¿ëÀ¸·Î ÁøÇàµÆ´Ù. Áß¶û±¸ ¼¼ÀÌÇÁ¾à±¹ »ç¾÷ Âü¿© ¾à±¹Àº °Ç°Á¦ÀϿ´©¸®¾à±¹, ¼ö¾à±¹, »ç°¡Á¤¾à±¹, ´ö¼ö¾à±¹, Çϳª¾à±¹, »õºÀȾ౹, ´ÃǪ¸¥¿Â´©¸®¾à±¹, Âü¾à»çM¹Ù¸¥¾à±¹, ¿À·»Áö¾à±¹, µ¿³²¾à±¹À¸·Î ÃÑ 10°÷ÀÌ´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ °½Å±¹ ±âÀÚ(ksk@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Áß¶û±¸¾à, ¼¼ÀÌÇÁ¾à±¹ Âü¿©¾à»ç ´ë»ó ±³À° URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Áß¶û±¸¾à, ¼¼ÀÌÇÁ¾à±¹ Âü¿©¾à»ç ´ë»ó ±³À° ±â»çÀÔ·Â : 19.06.21 08:59:31 0 °¡ ÇÃÄ£Ãß°¡ ¼¿ï Áß¶û±¸¾à»çȸ(ȸÀå ±èÀ§ÇÐ)´Â 19ÀÏ ±¸¾à»çȸ°ü¿¡¼ ¼¼ÀÌÇÁ¾à±¹ »ç¾÷ Âü¿©¾à±¹À» ´ë»óÀ¸·Î ±³À°À» ÁøÇàÇß´Ù. ±³À°Àº ¹ÚÇý°æ ÀǾàǰÁ¤Ã¥¿¬±¸¼ÒÀåÀÇ °ÀÇ·Î ¼¼ÀÌÇÁ¾à±¹ÀÇ ÃëÁö¿Í »ç¾÷¸ñÀû, »ó´ã¹æ¹ý µî ´Ù¾çÇÑ ³»¿ëÀ¸·Î ÁøÇàµÆ´Ù. Áß¶û±¸ ¼¼ÀÌÇÁ¾à±¹ »ç¾÷ Âü¿© ¾à±¹Àº °Ç°Á¦ÀϿ´©¸®¾à±¹, ¼ö¾à±¹, »ç°¡Á¤¾à±¹, ´ö¼ö¾à±¹, Çϳª¾à±¹, »õºÀȾ౹, ´ÃǪ¸¥¿Â´©¸®¾à±¹, Âü¾à»çM¹Ù¸¥¾à±¹, ¿À·»Áö¾à±¹, µ¿³²¾à±¹À¸·Î ÃÑ 10°÷ÀÌ´Ù. X AD ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ °½Å±¹ ±âÀÚ(ksk@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Áß¶û±¸¾à, ¼¼ÀÌÇÁ¾à±¹ Âü¿©¾à»ç ´ë»ó ±³À° URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö